Business Context and Reporting Period
Company: NUR Macroprinters Ltd. (Nasdaq-SCM: NURM)
Filing Type: Form 6-K (Press Release)
Reporting Period: Second Quarter ended June 30, 2004
Business Overview: A leading supplier of wide-format inkjet production printing systems for out-of-home advertising materials, operating in over 100 countries.
Key Financial Metrics
| Metric | Q2 2004 (GAAP) | Q2 2003 (GAAP) | YTD 6 Months 2004 (GAAP) |
|---|---|---|---|
| Revenues | $20.5 million | $13.1 million | $39.0 million |
| Gross Profit Margin | 39.7% | (2.0%) | 39.3% |
| Operating Income | $1.2 million | ($15.4 million) | $1.5 million |
| Net Income (Loss) | $233,000 | ($16.0 million) | ($743,000) |
| Diluted EPS | $0.01 | ($0.93) | ($0.03) |
| Cash and Equivalents | $14.7 million | N/A | N/A |
| Total Debt (Short + Long Term) | $45.5 million | N/A | N/A |
| Shareholders' Equity | $2.5 million | N/A | N/A |
Note: Q2 2003 GAAP results included significant one-time charges ($5.5M inventory write-offs, $6.7M doubtful debts, $2.1M restructuring). On a non-GAAP basis, Q2 2003 operating loss was $1.1 million and net loss was $1.7 million.
Material Changes vs. Prior Period
- Revenue Growth: Q2 2004 revenue increased 56% year-over-year and 11% quarter-over-quarter, driven by increased sales of Tempo and Fresco II systems in the USA and Far East.
- Profitability Turnaround: The company reported a net profit for the first time in three years. This marks the fourth consecutive quarter of financial and operational improvements.
- Margin Expansion: Gross margin improved significantly from a negative 2.0% in Q2 2003 (due to one-time write-offs) to 39.7% in Q2 2004.
- Balance Sheet: Shareholders' equity turned positive to $2.5 million from a deficit of $1.5 million at year-end 2003. Cash and cash equivalents increased from $10.9 million to $14.7 million.
Guidance, Outlook, and Risks
Full Year 2004 Guidance
- Revenue: Expected to be between $80 million and $82 million.
- Net Profit: Expected to be between $2.0 million and $2.5 million ($0.07 to $0.10 per share).
Management Commentary
Management highlighted the successful turnaround and the positive traction of new products. The development of the "Expedio" super-wide UV inkjet press is on schedule, with beta-tests expected soon. The company confirmed compliance with Nasdaq SmallCap Market listing requirements based on its current equity position.
Risks and Contingencies
- Forward-Looking Risks: Potential decline in demand, inability to timely develop new technologies, loss of market share, and pricing pressure from competition.
- Regulatory: The company is monitoring compliance with Nasdaq listing rules, specifically regarding equity levels.
Investor Verification Checklist
- Profitability Sustainability: Verify if the Q2 net profit is sustainable without the exclusion of one-time charges seen in prior periods.
- Debt Obligations: Review the total debt load of approximately $45.5 million against the $14.7 million cash position to assess liquidity risks.
- Product Pipeline: Confirm the timeline and market reception of the upcoming "Expedio" UV inkjet press beta-tests.
- Listing Compliance: Monitor future equity levels to ensure continued compliance with Nasdaq SmallCap Market Rule 4310(c)(2).
- Revenue Concentration: Assess the reliance on the USA and Far East markets for the reported revenue growth.